GRACEcast
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (audio)
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:19:29
- More information
Informações:
Synopsis
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews data supporting a method to define prognosis in early stage non-small cell lung cancer (NSCLC) based on molecular signatures and proposes a new staging system.
